Wed, Apr 16, 2014, 1:17 AM EDT - U.S. Markets open in 8 hrs 13 mins

Recent

% | $
Quotes you view appear here for quick access.

Teva Pharmaceutical Industries Limited Message Board

redshington_washskins2 7 posts  |  Last Activity: Apr 1, 2014 10:40 AM Member since: Apr 21, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • redshington_washskins2 redshington_washskins2 Apr 1, 2014 10:40 AM Flag

    You had to subtract them each separately? lol, what a math whiz.

  • Reply to

    Natco vs TEVA - news

    by sureshnageswaran Mar 1, 2014 8:29 AM
    redshington_washskins2 redshington_washskins2 Mar 3, 2014 8:41 AM Flag

    Dumb statement. Teva didn't change the pill color. Scientists invented the medicine in Israel and TEVA owns the rights. In sane countries, patents protect inventions. Natco has simply copied it.
    Even the language you and the indiatimes uses is distorted (or perhaps you don't understand english). It's not "monopoly" to have personal property.

  • Reply to

    Natco vs TEVA - news

    by sureshnageswaran Mar 1, 2014 8:29 AM
    redshington_washskins2 redshington_washskins2 Mar 2, 2014 8:08 PM Flag

    There is absolutely no respect for intellectual property or innovation in India. Anyone expecting a different result than this must have been living in a dreamworld. Any rip-off and scam gets govt and court sanction in India to steal the inventions of American companies. It doesn't change the fact that Mylan needs to get FDA approval, the FDA *might require clinical trials, and even the May 2014 patent expiration date is not *fully resolved yet as TEVA has appealed that decision. But again, patent expiration does not guarantee an approval without clinical trials proving equivalence.

  • Reply to

    What is Teva

    by bottomfeeder0103 Feb 17, 2014 1:06 PM
    redshington_washskins2 redshington_washskins2 Feb 23, 2014 12:43 PM Flag

    wrong.

  • Reply to

    teva's advance

    by skid1949 Feb 22, 2014 6:00 PM
    redshington_washskins2 redshington_washskins2 Feb 23, 2014 12:37 PM Flag

    The corporate governance is being changed, that is what changed materially to let investors take their guard down. It was a bargain before, people just unwilling to buy, now eased up a bit. From 55 down to 35 you could have asked the same question, "what has materially changed?" to cause the price to drop. If anything, they had some success in fending off Copaxone challengers the past few years and there is STILL no purported generic approved after giddy MNTA analysts were saying back 5 years ago that "we could see a generic as early as THIS year" lol, nope. There is significant value here that was being ignored, now it's getting more attention. Their generics business hit a lull and copaxone will hurt if a so-called generic is allowed onto market but teva has a pipeline too and in worst case scenario they still take in over 10 billion in revs and give a solid dividend while we await better times. But if worst-case scenario does not come about? Then the stock is undervalued and has significant upside.

  • Reply to

    Where is Maxirnus?

    by bottomfeeder0103 Feb 20, 2014 2:21 PM
    redshington_washskins2 redshington_washskins2 Feb 23, 2014 12:31 PM Flag

    Atty, you act is if no one was adding in the 30's. Come on. We know a bargain when we see one. Now market is waking up to it. That's called wise investment strategy. Something TA can't achieve but common sense can. Now I'm sure the TA has turned AFTER the stock already has. So you can get on board, too.

  • Reply to

    Glad To See

    by attymdmnola Jan 22, 2014 2:40 PM
    redshington_washskins2 redshington_washskins2 Jan 27, 2014 9:55 PM Flag

    TEVA passed on RNN and you think that's a sign of bad management? Huh? And because you got a "triple" holding RNN stock, that means a company (specifically teva) should have bought them out? Why should teva buy a junk company? The stock moves are irrelevant - there is no compelling reason at all for Teva to buy RNN. I'm sick of the misguided purchases of or deals for extremely unlikely candidates by Teva management. I want to see a deal with real value in it and big upside based on exciting science. Wake me up when RNN can be described as exciting.

TEVA
49.61-0.34(-0.68%)Apr 15 4:06 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.